Advanced Cell Diagnostics lines up $12M Series B round

Diagnostic test developer Advanced Cell Diagnostics Inc. completed a $12 million Series B financing, led by New Leaf Venture Partners.

The Hayward company, which developed its RNAscope technology to detect and quantify RNA biomarkers, said existing investor Morningside Ventures also participated in the round.